Comparative Efficacy and Safety of Golimumab, Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis: A Bayesian Indirect Treatment Comparison Meta-Analysis

Value in Health - United Kingdom

doi 10.1016/j.jval.2014.03.213